Outcomes analysis in HER2-low gastric cancer using multimodal RWD

RWD analysis reveals a poor prognosis for HER2-low gastric cancer patients

INDICATION

Gastric

BIOMARKER

HER2

Related cases

Unable to determine image content.

Characterizing CLDN18.2 and HER2 expression in gastroesophageal cancer

Two pixelated diamond shapes, one purple and one green, with unreadable text below.

Comparing molecular landscapes of early and average onset enteropancreatic NETs

Data visualization showing two dot plot distributions, one blue and one pink, on a white grid.

Molecular and clinical characterization of HER2-low versus HER2-0 breast cancer